The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus (Q40106075)

17 September 2017

The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

17 September 2017

1 reference

Hua-Tuo Huang

1

1 reference

17 September 2017

Jian-Ming Chen

2

1 reference

17 September 2017

Jing Guo

3

1 reference

17 September 2017

Yan Lan

4

1 reference

17 September 2017

Ye-Sheng Wei

5

1 reference

17 September 2017

14 January 2016

1 reference

Rheumatology International

17 September 2017

1 reference

17 September 2017

36

1 reference

17 September 2017

6

1 reference

17 September 2017

799-805

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-016-3422-6

17 September 2017

0 references

cites work

Interleukin-6 promoter polymorphisms (-174 G/C) in Malaysian patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Glucocorticoid downregulates expression of IL-12 family cytokines in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

The multifaceted balance of TNF-α and type I/II interferon responses in SLE and RA: how monocytes manage the impact of cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Structures and biological functions of IL-31 and IL-31 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

IL-31: a new link between T cells and pruritus in atopic skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Characterization of the signaling capacities of the novel gp130-like cytokine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Identifying Polymorphisms in IL-31 and Their Association with Susceptibility to Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

IL-31 associated with coronary artery lesion formation in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Interleukin-6 promotes systemic lupus erythematosus progression with Treg suppression approach in a murine systemic lupus erythematosus model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Interleukin 1, interleukin 6, interleukin 10, and tumor necrosis factor α in active and quiescent systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Association of the interleukin-6 polymorphisms with systemic lupus erythematosus: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

A New Statistical Method for Haplotype Reconstruction from Population Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

GPL, a Novel Cytokine Receptor Related to GP130 and Leukemia Inhibitory Factor Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Distinct SPINK5 and IL-31 polymorphisms are associated with atopic eczema and non-atopic hand dermatitis in Taiwanese nursing population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-016-3422-6

Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis

21 January 2018

1 reference

12 December 2020

Functional effects of interleukin 31 in human primary keratinocytes

1 reference

12 December 2020

A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema

1 reference

12 December 2020

The association of interleukin-21 polymorphisms with interleukin-21 serum levels and risk of systemic lupus erythematosus

1 reference

12 December 2020

Association of distinct IL-31 polymorphisms with pruritus and severity of atopic dermatitis

1 reference

12 December 2020

Correlations between concentrations of interleukin (IL)-17A, IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients

1 reference

12 December 2020

Interleukin-31 stimulates production of inflammatory mediators from human colonic subepithelial myofibroblasts

1 reference

12 December 2020

Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins

1 reference

12 December 2020

IL-31 receptor alpha expression in epidermal keratinocytes is modulated by cell differentiation and interferon gamma

1 reference

12 December 2020

Increased interleukin-4 production by NK T cells in systemic lupus erythematosus

1 reference

12 December 2020

Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis

1 reference

12 December 2020

Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma

1 reference

12 December 2020

IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis

1 reference

12 December 2020

10.1007/S00296-016-3422-6

Identifiers

DOI

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference